Compare · ALH vs TMO
ALH vs TMO
Side-by-side comparison of Alliance Laundry Holdings Inc. (ALH) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALH and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.53B, about 61.9x ALH ($4.16B).
- TMO has been more active in the news (6 items in the past 4 weeks vs 3 for ALH).
- TMO has more recent analyst coverage (25 ratings vs 8 for ALH).
- Company
- Alliance Laundry Holdings Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $4.16B
- $257.53B
- 1M return
- -0.47%
- -
- 1Y return
- -14.54%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2025
- News (4w)
- 3
- 6
- Recent ratings
- 8
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ALH
- COO - International Calver Robert John was granted 7,065 shares, increasing direct ownership by 241% to 9,998 units (SEC Form 4)
- New insider Calver Robert John claimed ownership of 2,933 shares (SEC Form 3)
- COO - INTERNATIONAL Vleugels Jan Gommaar M. exercised 778,008 shares at a strike of $5.79 and covered exercise/tax liability with 206,639 shares, increasing direct ownership by 153% to 945,932 units (SEC Form 4)
- COO - INTERNATIONAL Vleugels Jan Gommaar M. sold $1,578,750 worth of shares (75,000 units at $21.05) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 374,563 units (SEC Form 4)
- Alliance Receives Credit Ratings Upgrade from S&P Global Ratings
- Amendment: SEC Form 3 filed by new insider Ashurst Gary Robert
- CCO - North America Ashurst Gary Robert was granted 10,476 shares (SEC Form 4)
- SEC Form 3 filed by new insider Ashurst Gary Robert
- Director Bdt Capital Partners, Llc sold $589,606,506 worth of shares (25,932,500 units at $22.74) (SEC Form 4)
- SEC Form 424B4 filed by Alliance Laundry Holdings Inc.
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)